跳至主要内容
临床试验/NCT05371977
NCT05371977招募中不适用

Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma

Helsinki University Central Hospital2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2022年5月31日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
80
试验地点
2
主要终点
Success Rate

研究概览

简要总结

The purpose of this study is to assess whether deep sclerectomy is as effective in lowering intraocular pressure (IOP) as trabeculectomy in patients with normal tension glaucoma.

详细描述

Subjects with normal tension glaucoma that is unstable with current medication needing filtration surgery are recruited in the study. All patients meeting the inclusion criteria and giving informed consent will be randomized to whether having deep sclerectomy or trabeculectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
55 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed Informed Consent
  • Normal Tension Glaucoma with typical nerve fiber layer defects in red-free photographs and/or optical coherence tomography (OCT) and possible equivalent visual field defects, IOP never more than 21 mmHg, and open anterior chamber angle
  • Glaucoma unstable with current medication assessed by a glaucoma specialist

排除标准

  • Secondary Glaucoma e.g. due to previous injury or uveitis
  • Exfoliation syndrome
  • Pigment dispersion syndrome
  • Previous transscleral or endoscopic cyclophotocoagulation
  • Previous other glaucoma surgery
  • Previous retinal detachment
  • Previous intraocular surgery like vitrectomy and other retinal surgery
  • Wet age-related macular degeneration
  • Diabetic retonopathy
  • Previous corneal transplant or previous refractive surgery
  • Fuchs' dystrophy and other abnormalities compromising corneal clarity like scars
  • The patient does not want to participate in the study
  • The patient does not speak Finnish, Swedish or English
  • Only eye with vision worse than 20/200 or loss of central visual field

结局指标

主要结局

Success Rate

时间窗: One year

Decrease in Intraocular Pressure of 20 % or more or former level with fewer medications

次要结局

  • Success Rate(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nina Lindbohm

Principal Investigator

Helsinki University Central Hospital

研究点 (2)

Loading locations...

相似试验

Deep Sclerectomy Versus Trabeculectomy in Normal... | 临床试验